IMC Chicago’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$700K Sell
61,800
-1,600
-3% -$15.7K ﹤0.01% 4265
2026
Q1
$400K Sell
63,400
-15,800
-20% -$142K ﹤0.01% 4272
2025
Q4
$847K Sell
79,200
-8,200
-9% -$90.1K ﹤0.01% 3118
2025
Q3
$1.09M Buy
87,400
+13,400
+18% +$137K ﹤0.01% 2650
2025
Q2
$756K Buy
74,000
+29,700
+67% +$261K ﹤0.01% 2635
2025
Q1
$350K Buy
+44,300
New +$545K ﹤0.01% 2851

Other funds holding CRNC

IMC Chicago's CRNC Position: Q2 2026 in Review

IMC Chicago increased its Cerence (CRNC) stake by 202% in Q2 2026, buying an estimated $682K and bringing the position to 104,104 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3651.

IMC Chicago first reported a position in CRNC in Q2 2025 and has held it in 3 quarters since. 196 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • IMC Chicago held 104,104 shares of Cerence worth $1.18M as of Q2 2026.
  • IMC Chicago bought 69,583 Cerence shares in Q2 2026, an estimated $682K.
  • Cerence made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3651 holding.
  • IMC Chicago first reported a position in Cerence in Q2 2025 and has held it in 3 quarters since.
  • 196 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.